CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 209 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02803580
NCT02803580N/ACompleted

IPF Italian Observational Study (FIBRONET)

Boehringer Ingelheim·observational·Posted Jun 17, 2016·Updated Sep 13, 2019

In Brief

An observational study for Idiopathic Pulmonary Fibrosis. Completed, enrolled 209 participants across 18 sites.

Detailed Summary

The purpose of the present study is to evaluate the characteristics, management and clinical course of patients with IPF as treated under real-world in Italian Pulmonary Centres, in terms of symptoms, lung function and exercise tolerance during 12 months of observation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 17, 2016
Enrollment StartNov 17, 2015
Primary CompletionMay 15, 2018
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 10.0 years ago